These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28984800)

  • 21. Integrating germline and somatic data towards a personalized cancer medicine.
    Pujana MA
    Trends Mol Med; 2014 Aug; 20(8):413-5. PubMed ID: 25086750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics.
    Johnson LM; Valdez JM; Quinn EA; Sykes AD; McGee RB; Nuccio R; Hines-Dowell SJ; Baker JN; Kesserwan C; Nichols KE; Mandrell BN
    Cancer; 2017 Jun; 123(12):2352-2359. PubMed ID: 28192596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications.
    Laguna JC; Pastor B; Nalda I; Hijazo-Pechero S; Teixido C; Potrony M; Puig-Butillé JA; Mezquita L
    Br J Cancer; 2024 May; 130(9):1420-1431. PubMed ID: 38532104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of Genomic Sequencing in Pediatric CNS Tumors.
    Bavle AA; Lin FY; Parsons DW
    Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.
    Ripperger T; Bielack SS; Borkhardt A; Brecht IB; Burkhardt B; Calaminus G; Debatin KM; Deubzer H; Dirksen U; Eckert C; Eggert A; Erlacher M; Fleischhack G; Frühwald MC; Gnekow A; Goehring G; Graf N; Hanenberg H; Hauer J; Hero B; Hettmer S; von Hoff K; Horstmann M; Hoyer J; Illig T; Kaatsch P; Kappler R; Kerl K; Klingebiel T; Kontny U; Kordes U; Körholz D; Koscielniak E; Kramm CM; Kuhlen M; Kulozik AE; Lamottke B; Leuschner I; Lohmann DR; Meinhardt A; Metzler M; Meyer LH; Moser O; Nathrath M; Niemeyer CM; Nustede R; Pajtler KW; Paret C; Rasche M; Reinhardt D; Rieß O; Russo A; Rutkowski S; Schlegelberger B; Schneider D; Schneppenheim R; Schrappe M; Schroeder C; von Schweinitz D; Simon T; Sparber-Sauer M; Spix C; Stanulla M; Steinemann D; Strahm B; Temming P; Thomay K; von Bueren AO; Vorwerk P; Witt O; Wlodarski M; Wössmann W; Zenker M; Zimmermann S; Pfister SM; Kratz CP
    Am J Med Genet A; 2017 Apr; 173(4):1017-1037. PubMed ID: 28168833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr.
    Brodeur GM; Nichols KE; Plon SE; Schiffman JD; Malkin D
    Clin Cancer Res; 2017 Jun; 23(11):e1-e5. PubMed ID: 28572261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic mutations and germline sequence variants in patients with familial colorectal cancer.
    Gylfe AE; Sirkiä J; Ahlsten M; Järvinen H; Mecklin JP; Karhu A; Aaltonen LA
    Int J Cancer; 2010 Dec; 127(12):2974-80. PubMed ID: 21351276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical Methods for Integrating Genetic Testing Into Clinical Practice for Advanced Prostate Cancer.
    Cheng H; Powers J; Schaffer K; Sartor O
    Am Soc Clin Oncol Educ Book; 2018 May; 38():372-381. PubMed ID: 30231311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic implications of germline genetic findings in cancer.
    Thavaneswaran S; Rath E; Tucker K; Joshua AM; Hess D; Pinese M; Ballinger ML; Thomas DM
    Nat Rev Clin Oncol; 2019 Jun; 16(6):386-396. PubMed ID: 30783251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline Testing for the Evaluation of Hereditary Cancer Predisposition.
    Ceyhan-Birsoy O
    Clin Lab Med; 2022 Sep; 42(3):497-506. PubMed ID: 36150826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic testing in patients with cancer; new developments].
    Ausems MGEM; Oosterwijk JC; Nielsen M; Lolkema MP; Hoogerbrugge N; Ligtenberg MJL
    Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31140768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer molecular markers: A guide to cancer detection and management.
    Nair M; Sandhu SS; Sharma AK
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):39-55. PubMed ID: 29428478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with negative multi-gene panel testing: a back to the future paradox?
    Sorscher SM
    Fam Cancer; 2017 Jul; 16(3):459. PubMed ID: 28258424
    [No Abstract]   [Full Text] [Related]  

  • 36. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
    Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
    JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer predisposition syndromes: lessons for truly precision medicine.
    Glaire MA; Brown M; Church DN; Tomlinson I
    J Pathol; 2017 Jan; 241(2):226-235. PubMed ID: 27859368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline Mutations in Predisposition Genes in Pediatric Cancer.
    Bardai A; Overwater E; Aalfs CM
    N Engl J Med; 2016 Apr; 374(14):1390-1. PubMed ID: 27050225
    [No Abstract]   [Full Text] [Related]  

  • 39. Germline Mutations in Predisposition Genes in Pediatric Cancer.
    Zhang J; Nichols KE; Downing JR
    N Engl J Med; 2016 Apr; 374(14):1391. PubMed ID: 27050224
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing.
    Kuhlen M; Borkhardt A
    Eur J Pediatr; 2015 Aug; 174(8):987-97. PubMed ID: 25982339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.